Literature DB >> 24337854

Left ventricle geometry remolding after heart transplantation: a two-dimensional ultrasound study.

Xiao-Juan Qin1, He Li1, Jun You1, Qing Lv1, Jing Zhang2, Han-Jing Gao3, Ming-Xing Xie4.   

Abstract

The function of the transplanted heart will be affected by acute allograft rejection, chronic rejection, high blood pressure and so on, which may induce the reconstruction of the left ventricle and the increase of left ventricular mass (LVM), and eventually lead to left ventricular hypertrophy that will significantly affect the prognosis of heart transplantation (HT). The purpose of this study was to dynamically monitor the changes of left ventricular geometric patterns after HT using two-dimensional echocardiography and to understand the remodeling process and its possible influencing factors. The left ventricular internal diameter, interventricular septal wall thickness, posterior wall thickness at end diastole were measured and the relative wall thickness (RWT), left ventricular mass, left ventricular mass index were calculated respectively in 34 HT patients and 34 healthy volunteers by two-dimensional echocardiography. The type of left ventricular geometry was identified based on the echocardiographic determination of LVM index (LVMI) and RWT. The HT patients were divided into three groups according to the time length after surgery: A (3 months postoperatively), B (6 months postoperatively) and C (12 months postoperatively). We compared the parameters of left ventricle between HT group and normal control group, and explored the risk factors causing the increase of LVM. The results showed that 4 patients (16%) in group A had concentric remodeling. Nine patients (34.62%) in group B had reconstruction, including 5 cases of concentric remodeling, 2 cases of concentric hypertrophy and 2 cases of eccentric hypertrophy. The hypertrophy incidence rate was 15.4% in group B. 15 patients (62.5%) had reconstruction in group C, including 9 cases of concentric remodeling, 5 cases of concentric hypertrophy, and 1 case of eccentric hypertrophy. The prevalence of hypertrophy was 25%. Multivariate analysis showed that hypertension and acute rejection history were the risk factors that resulted in left ventricular hypertrophy. It is concluded that the left ventricular remodeling occurs following cardiac transplantation at an early stage and the incidence of left ventricular hypertrophy increases with survival time. In this study, the one-year prevalence of left ventricular hypertrophy was 25% after surgery. Hypertension and acute rejection history are risk factors that can predict the left ventricular hypertrophy.

Entities:  

Mesh:

Year:  2013        PMID: 24337854     DOI: 10.1007/s11596-013-1217-5

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  20 in total

1.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology.

Authors:  Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack S Shanewise; Scott D Solomon; Kirk T Spencer; Martin St John Sutton; William J Stewart
Journal:  J Am Soc Echocardiogr       Date:  2005-12       Impact factor: 5.251

2.  Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult lung and heart-lung transplant report--2005.

Authors:  Elbert P Trulock; Leah B Edwards; David O Taylor; Mark M Boucek; Berkeley M Keck; Marshall I Hertz
Journal:  J Heart Lung Transplant       Date:  2005-08       Impact factor: 10.247

3.  Severe left ventricular hypertrophy 1 year after transplant predicts mortality in cardiac transplant recipients.

Authors:  Randy Goodroe; D Dirk Bonnema; Shayna Lunsford; Phillip Anderson; Barbara Ryan-Baille; Walt Uber; John Ikonomidis; Arthur J Crumbley; Adrian VanBakel; Michael R Zile; Naveen Pereira
Journal:  J Heart Lung Transplant       Date:  2007-02       Impact factor: 10.247

4.  Assessment of early left ventricular remodeling in orthotopic heart transplant recipients with cine magnetic resonance imaging: potential mechanisms.

Authors:  S Globits; T De Marco; J Schwitter; H Sakuma; M O'Sullivan; C Rifkin; F Keith; K Chatterjee; W W Parmley; C B Higgins
Journal:  J Heart Lung Transplant       Date:  1997-05       Impact factor: 10.247

5.  Cardiac transplantation in man. 8. Survival and function.

Authors:  E B Stinson; R B Griepp; D A Clark; E Dong; N E Shumway
Journal:  J Thorac Cardiovasc Surg       Date:  1970-09       Impact factor: 5.209

6.  The effect of exercise and atrial pacing on left ventricular volume and contractility in patients with innervated and denervated hearts.

Authors:  P R McLaughlin; J H Kleiman; R P Martin; P W Doherty; B Reitz; E B Stinson; G T Daughters; N B Ingels; E L Alderman
Journal:  Circulation       Date:  1978-09       Impact factor: 29.690

7.  Left ventricular mass by M-mode echocardiography in cardiac transplant patients with acute rejection.

Authors:  K B Sagar; A Hastillo; T C Wolfgang; R R Lower; M L Hess
Journal:  Circulation       Date:  1981-08       Impact factor: 29.690

8.  Hypertension and left ventricular hypertrophy in black vs white heart transplant patients 1 year after surgery.

Authors:  B Czerska; R W Stewart; R E Hobbs; A L Klein; H M Lever; G Rincon; N B Ratliff; M D Schluchter; F M Fouad-Tarazi
Journal:  Ethn Dis       Date:  1991       Impact factor: 1.847

9.  Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death.

Authors:  A W Haider; M G Larson; E J Benjamin; D Levy
Journal:  J Am Coll Cardiol       Date:  1998-11       Impact factor: 24.094

10.  Cardiovascular adaptation to cyclosporine-induced hypertension.

Authors:  H O Ventura; C J Lavie; F H Messerli; V Valentino; F W Smart; D D Stapleton; J L Ochsner
Journal:  J Hum Hypertens       Date:  1994-04       Impact factor: 3.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.